134. Septo-optic dysplasia Clinical trials / Disease details


Clinical trial : 1 Drug : 1 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00140413
(ClinicalTrials.gov)
December 200431/8/2005Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve HypoplasiaEndocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve HypoplasiaGrowth Hormone Deficiency;Septo-Optic Dysplasia;HypopituitarismDrug: Nutropin AQChildren's Hospital Los AngelesGenentech, Inc.CompletedN/A5 YearsAll20Phase 4United States